A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature

被引:1
|
作者
Puhr, Hannah Christina [1 ,2 ]
Ilhan-Mutlu, Ayseguel [1 ,2 ]
机构
[1] Med Univ Vienna, Div Oncol, Dept Med 1, Vienna, Austria
[2] Med Univ Vienna, Upper Gastrointestinal Tumors Unit, Comprehens Canc Ctr Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
关键词
Gastric cancer; Upper GI cancer; HER2; Trastuzumab; Ramucirumab; GASTROESOPHAGEAL JUNCTION CANCER; HER2; STATUS; OPEN-LABEL; TRASTUZUMAB; CHEMOTHERAPY; ESOPHAGEAL; PROGNOSIS;
D O I
10.1007/s12254-020-00649-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognosis of patients with metastatic gastroesophageal cancer remains poor despite numerous promising clinical trials, and the clinical benefit of systemic therapies is under critical review. This case report of a patient with human epidermal growth factor receptor 2 (HER2)-positive metastatic gastric adenocarcinoma is an impulse for the importance of individual decision making and molecular guided treatment options.
引用
收藏
页码:453 / 458
页数:6
相关论文
共 50 条
  • [21] Cerebrospinal Fluid Cytology Diagnosis of HER2-Positive Leptomeningeal Carcinomatosis From HER2-Positive Metastatic Gastric Cancer: Case Report
    Cavanna, Luigi
    Rocchi, Andrea
    Gorgni, Silvia
    Ambroggi, Massimo
    Foroni, Raoul P.
    Ubbiali, Alessandro
    Civardi, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (13) : E367 - E368
  • [22] Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report
    Li, Wei-Ling
    Zhang, Ying
    Zhang, Xiao-Ling
    Du, Yun-Yi
    Hu, Wen-Qing
    Zhao, Jun
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [23] Trastuzumab in HER2-Positive Metastatic Gastric Cancer Profile Report
    Croxtall, Jamie D.
    McKeage, Kate
    BIODRUGS, 2011, 25 (04) : 257 - 259
  • [24] Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma
    Porth, Isabel
    Hirsch, Daniela
    Ceribas, Yonca
    Weidner, Philip
    Weichert, Wilko
    Goetze, Thorsten Oliver
    Perner, Sven
    Luley, Kim
    Heyer, Christian Moritz
    de la Torre, Carolina
    Hofheinz, Ralf-Dieter
    Lorenzen, Sylvie
    Gaiser, Timo
    EUROPEAN JOURNAL OF CANCER, 2023, 183 : 119 - 130
  • [25] Long-Term Survival of a Patient with Giant Cell Glioblastoma: Case Report and Review of the Literature
    Naydenov, E.
    Bussarsky, V.
    Nachev, S.
    Hadjidekova, S.
    Toncheva, D.
    CASE REPORTS IN ONCOLOGY, 2009, 2 (02): : 103 - 110
  • [26] Long-Term Survival of FOLFIRINOX plus toripalimab in a Patient with Metastatic Pancreatic Ductal Adenocarcinoma: A Case Report
    Jiang, Ting
    Gao, Chen
    Luo, Yiyang
    Ye, Zixiang
    Wang, Binbin
    ONCOTARGETS AND THERAPY, 2022, 15 : 883 - 890
  • [27] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
    Mueller, Volkmar
    Clemens, Michael
    Jassem, Jacek
    Al-Sakaff, Nedal
    Auclair, Petra
    Nuesch, Eveline
    Holloway, Debbie
    Shing, Mona
    Bang, Yung-Jue
    BMC CANCER, 2018, 18
  • [28] Long-term trastuzumab (Herceptin®) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer
    Volkmar Müller
    Michael Clemens
    Jacek Jassem
    Nedal Al-Sakaff
    Petra Auclair
    Eveline Nüesch
    Debbie Holloway
    Mona Shing
    Yung-Jue Bang
    BMC Cancer, 18
  • [29] Long-term survival of an elderly patient with advanced gastric cancer after combination therapy: a case report and literature review
    Qingwei Li
    Xuejun Xu
    Dan Su
    Tianshuo Zhou
    Guangyu Wang
    Zhiwei Li
    BMC Cancer, 19
  • [30] Long-term survival of an elderly patient with advanced gastric cancer after combination therapy: a case report and literature review
    Li, Qingwei
    Xu, Xuejun
    Su, Dan
    Zhou, Tianshuo
    Wang, Guangyu
    Li, Zhiwei
    BMC CANCER, 2019, 19